Therapy Areas: Infectious Diseases
PanTheryx Names Oz to Board of Directors
18 September 2019 - - US-based biotechnology company PanTheryx has appointed Dr. Mehmet C. Oz, MD, surgeon and talk show host "Dr. Oz" from The Dr. Oz Show, to the company's board of directors, the company said.

With this new appointment, Oz will advise PanTheryx on strategies to expand its impact on health and wellness through its leading technology position and focus on colostrum science.

Oz brings decades of medical, nutrition, wellness, and communications expertise to the PanTheryx board.

As former vice-chair and professor of surgery at Columbia University Medical Center, Oz is a world-renowned practicing cardiothoracic surgeon who has authored over 400 original publications, articles, and medical books.

He is also the host of the Emmy award-winning television series The Dr. Oz Show, as well as co-founder of HealthCorps, a national nonprofit with a mission to educate and improve physical and mental health in American teens.

PanTheryx was founded in 2007 to create nutritional solutions for pediatric infectious diarrhea, the second leading killer of children under the age of five in the developing world.

Capitalising upon the great potential of its patented technology platform, PanTheryx has evolved to leverage the cellular and biomolecular processes of bovine colostrum to develop and commercialize a wide range of nutritional interventions and first-in-class therapeutics.

Colostrum is rich in immunoglobulins, antimicrobial peptides, growth factors, cytokines and oligosaccharidesm, all of which can be targeted to produce specific therapeutic activity through PanTheryx's platform.

Oz joins other recent additions to the PanTheryx board including Dr. Rajiv Shah, MD, president of the Rockefeller Foundation, and Dr. Thomas Bumol, PhD, executive director of the Allen Institute for Immunology.

PanTheryx is a biotechnology company committed to realising the potential of bovine colostrum based therapies to address a range of health conditions.

The company commercializes first-in-class therapeutics, with products developed from its patented technology platform spanning the range of nutritional interventions to biologics.

Founded in 2007, PanTheryx is headquartered in Boulder, Colorado and has production facilities in Phoenix, AZ and Ripon, CA. Its flagship product, DiaResQ, is available in over 30,000 pharmacies and retail stores in the US.
Login
Username:

Password: